Photo taken from Angelo Dipasquale/LinkedIn
Jan 24, 2024, 08:34
Angelo Dipasquale: Which patient may benefit from inclusion in an early-phase trial with next-generation immunotherapies?
Angelo Dipasquale,
“Which patient may benefit from inclusion in an early-phase trial with next-generation immunotherapies? Find out our experience with interesting observations and a handy prognostic nomogram for clinical practice.”
Source: Angelo Dipasquale/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 28, 2025, 18:34
Feb 28, 2025, 15:34
Feb 28, 2025, 15:33
Feb 28, 2025, 15:25
Feb 28, 2025, 15:22
Feb 28, 2025, 15:20
Feb 28, 2025, 15:13
Feb 28, 2025, 15:02
Feb 28, 2025, 14:43
Feb 28, 2025, 14:37